Evidence map›Paper›PMID 33948391›Full record

ArticleAmerican journal of cancer research2021

Erratum: Epidemiology of and prognostic factors for patients with sarcomatoid carcinoma: a large population-based study.

Zihan Xu, Li Wang, Li Tu, Yanyang Liu, Xiaoxiao Xie, Xiaojun Tang, Feng Luo

Abstract readPublished Erratum
PubMed Full text at PMC
In one paragraph

Article in American journal of cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Zihan XuLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, P. R. China.
Li WangLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, P. R. China.
Li TuLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, P. R. China.
Yanyang LiuLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, P. R. China.
Xiaoxiao XieLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, P. R. China.
Xiaojun TangLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, P. R. China.
Feng LuoLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article on p. 3801 in vol. 10, PMID: 33294268.].

Identifiers

PMID33948391
PMCPMC8085883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.